​

Pulse Biosciences (PLSE) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

PLSE Stock Forecast

Pulse Biosciences (PLSE) stock forecast, based on 6 Wall Street analysts, predicts a 12-month average price target of $60.20, with a high of $70.00 and a low of $55.00. This represents a 14.27% increase from the last price of $52.68.

$10 $22 $34 $46 $58 $70 High: $70 Avg: $60.2 Low: $55 Last Closed Price: $52.68

PLSE Stock Rating

Pulse Biosciences stock's rating consensus is Buy, based on 6 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 4 Buy (66.67%), 2 Hold (33.33%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 6 2 4 0 Strong Sell Sell Hold Buy Strong Buy

PLSE Price Target Upside V Benchmarks

TypeNameUpside
StockPulse Biosciences14.27%
SectorHealthcare Stocks 15.45%
IndustryMedical Instruments & Supplies Stocks5.98%

Price Target Trends

1M3M12M
# Anlaysts3812
Avg Price Target$57.67$53.00$45.08
Last Closing Price$52.68$52.68$52.68
Upside/Downside9.47%0.61%-14.43%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 2615---6
Sep, 2613---4
Aug, 26-3---3
Jul, 26-3---3
Jun, 26-2---2
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 13, 2026Mizuho Securities$55.00$52.454.86%4.40%
Oct 13, 2026Suraj KaliaOppenheimer$60.00$52.4514.39%13.90%
Oct 06, 2026William PlovanicCanaccord Genuity$58.00$50.5014.85%10.10%
Sep 23, 2026BTIG$70.00$52.6932.85%32.88%
Aug 17, 2026Needham$58.00$44.5430.22%10.10%
Aug 10, 2026Anthony PetroneMizuho Securities$45.00$42.416.11%-14.58%
Aug 10, 2026William PlovanicCanaccord Genuity$43.00$42.411.39%-18.38%
Jul 28, 2026Oppenheimer$35.00$32.796.74%-33.56%
Jun 04, 2026Canaccord Genuity$32.00$24.9928.05%-39.26%
Feb 20, 2026Suraj KaliaOppenheimer$30.00$22.0336.18%-43.05%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 13, 2026OppenheimerOutperformOutperformhold
Sep 23, 2026BTIGBuyinitialise
Aug 17, 2026NeedhamBuyinitialise
Jul 28, 2026OppenheimerOutperformOutperformhold
Feb 20, 2026OppenheimerOutperformOutperformhold

Financial Forecast

EPS Forecast

Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$-2.28$-1.72$-0.88$-0.92$-1.08-
Avg Forecast$-2.27$-1.75$-0.96$-0.95$-0.60$-0.47
High Forecast$-2.27$-1.75$-0.96$-0.95$-0.60$-0.47
Low Forecast$-2.27$-1.75$-0.96$-0.95$-0.60$-0.47
Surprise %0.44%-1.71%-8.33%-3.16%80.00%-

Revenue Forecast

$0 $7M $14M $21M $28M $35M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$1.42M$700.00K----
Avg Forecast$1.45M$709.00K-$800.00K$23.37M$34.47M
High Forecast$1.45M$709.00K-$800.00K$23.37M$34.47M
Low Forecast$1.45M$709.00K-$800.00K$23.37M$34.47M
Surprise %-1.94%-1.27%----

Net Income Forecast

$-110M $-92M $-74M $-56M $-38M $-20M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$-63.66M$-58.51M$-42.21M$-53.59M$-72.78M-
Avg Forecast$-109.05M$-84.07M$-46.12M$-45.64M$-28.82M$-22.58M
High Forecast$-109.05M$-84.07M$-46.12M$-45.64M$-28.82M$-22.58M
Low Forecast$-109.05M$-84.07M$-46.12M$-45.64M$-28.82M$-22.58M
Surprise %-41.62%-30.41%-8.47%17.42%152.51%-

PLSE Forecast FAQ

Is Pulse Biosciences stock a buy?

Pulse Biosciences stock has a consensus rating of Buy, based on 6 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 4 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Pulse Biosciences is a favorable investment for most analysts.

What is Pulse Biosciences's price target?

Pulse Biosciences's price target, set by 6 Wall Street analysts, averages $60.2 over the next 12 months. The price target range spans from $55 at the low end to $70 at the high end, suggesting a potential 14.27% change from the previous closing price of $52.68.

How does Pulse Biosciences stock forecast compare to its benchmarks?

Pulse Biosciences's stock forecast shows a 14.27% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical instruments & supplies stocks industry (5.98%).

What is the breakdown of analyst ratings for Pulse Biosciences over the past three months?

  • October 2026: 16.67% Strong Buy, 83.33% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • September 2026: 25.00% Strong Buy, 75.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • August 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Pulse Biosciences’s EPS forecast?

Pulse Biosciences's average annual EPS forecast for its fiscal year ending in December 2026 is $-0.47, marking a -56.48% decrease from the reported $-1.08 in 2025..

What is Pulse Biosciences’s revenue forecast?

Pulse Biosciences's average annual revenue forecast for its fiscal year ending in December 2026 is $34.47M, reflecting a 0% decrease from the reported $0 in 2025.

What is Pulse Biosciences’s net income forecast?

Pulse Biosciences's net income forecast for the fiscal year ending in December 2026 stands at $-22.578M, representing a -68.98% decrease from the reported $-72.781M in 2025.